Nu-Med Plus (NUMD) Cash from Operations Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) Cash from Operations Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.23% |
| Sep 30, 2025 | 35.34% |
| Dec 31, 2024 | 57.80% |
| Jun 30, 2024 | 54.64% |
| Mar 31, 2024 | 71.67% |
| Dec 31, 2023 | 50.45% |
| Sep 30, 2023 | 33.30% |
| Jun 30, 2023 | 25.35% |
| Mar 31, 2023 | 24.42% |
| Dec 31, 2022 | 29.39% |
| Sep 30, 2022 | 14.93% |
| Jun 30, 2022 | 50.98% |
| Mar 31, 2022 | 30.32% |
| Dec 31, 2021 | 13.33% |
| Sep 30, 2021 | -1.03% |
| Jun 30, 2021 | -5.93% |
| Mar 31, 2021 | -9.53% |
| Dec 31, 2020 | -8.44% |
| Sep 30, 2020 | -20.78% |
| Jun 30, 2020 | -22.78% |